Acasti Pharma Inc (NASDAQ: ACST) today delivered an apprise on its tactics to obtain Grace. As part of Acasti’s official procedure to inspect and assess various planned replacements to improve bondholder worth, the administration and the board assessed many corporations and steered an all-embracing and detailed due assiduousness procedure on […]

The stock of Acasti Pharma Inc (NASDAQ: ACST) rose by a margin of 6.8% to finally settle at $0.57.This company is excited to pronounce its entry into a definitive agreement, a deal that will see it win Grace Therapeutics to its side. Grace Therapeutics has been focusing on developing products […]